Autumn officially begins tomorrow, so whether you spend your weekend watching football, picking apples, or indulging in some pumpkin pie, make sure you leave room for our Research Ethics Roundup. This week’s installment features articles on recent protests over genetically modified organisms (GMOs) in China, the human side of clinical trials, and more!
Research Ethics Roundup: Examining the nocebo effect, new clinical trial rules in India, and more!
Tags:
India plans to reform oversight of medical research, while Harvard University agrees to restructure their Primate Center. Learn about these changes and more in this week’s Research Ethics Roundup!
Testing what we think we know: This opinion piece from The New York Times posits that researchers ought to spend less time investigating novel technologies, and more time evaluating whether standard treatments are actually effective and efficient.
by Farah Moulvi, MSPH, Institutional Animal Care and Use Program Manager and Biosafety Officer at the University of South Flordia
In sunny Florida, as summer sizzles on, I keep reminiscing about the buzz surrounding the Eighth Edition of the Guide for the Care and Use of Laboratory Animals (Guide) at the <[...] Read more
by Avery Avrakotos, Education and Policy Coordinator
I have to admit it—I’ve never read a thriller before. When I head into bookstores, my eyes always home in on the newest nonfiction releases. So when I picked up Paul McKellips’ 2011 release Uncaged: A Thriller, I was dubious of how long this book would last on my nightstand.
My instinct was right. It didn’t last long—McKellips’ [...] Read more
In this week’s Research Ethics Roundup, the 3Rs, bias in research, and compensation for research participants serve as food for thought.
What does the increase in numbers of animals used in research mean?: Statistics indicating that the use of animals in scientific research in the United Kingdom (UK) increased in 2011 were recently released. While some are concerned that this trend may indicate deviation from the 3Rs –reduction, refinement, and replacement– others believe the implications of these statistics may be more benign.
